Dasi Simulations

Based in the US, Dasi Simulations specializes in AI-driven solutions for healthcare, specifically enhancing interventional cardiology through patient-specific simulations that improve clinical decision-making and patient outcomes. Dasi Simulations, founded in 2019 and headquartered in Dublin, US, focuses on developing innovative AI-based tools for interventional cardiologists. The company has successfully raised USD 5. 00 mn, with its most recent funding round occurring on June 16, 2025.

This funding will support the expansion of sales and engineering teams and the development of new artificial intelligence tools. The founder's history is not detailed, and there are no mentions of prior ventures or subsidiaries. Dasi Simulations specializes in AI-driven simulations designed for interventional cardiologists, enhancing decision-making through patient-specific insights into heart conditions. The flagship offering is the Dasi Simulations AI Treatment App, which allows clinicians to visualize and optimize treatment plans for structural heart diseases, significantly improving patient outcomes.

This innovative technology is fully customizable, addressing unique patient needs by assessing potential complications that are often undetectable through traditional methods. The company primarily serves healthcare institutions, including hospitals and cardiology practices, across various geographical markets, with a focus on the United States and Europe. In addition to the AI Treatment App, Dasi offers advanced computational predictive modeling services, leveraging artificial intelligence and computer vision to reduce risks and costs associated with structural heart disease procedures. Dasi Simulations generates revenue through B2B transactions with healthcare providers, hospitals, and clinics using their proprietary technology and services.

The company operates on a subscription-based model, providing ongoing access to its AI-powered simulations and analytical tools as part of a comprehensive service package. This transactional structure includes tiered pricing plans, allowing healthcare institutions to choose the level of service and customization needed for their specific requirements. The Dasi Simulations AI Treatment App and predictive modeling services are core to their revenue generation, capitalizing on the increasing demand for advanced cardiac care solutions. Clients benefit from improved surgical planning and risk assessment, which translates into enhanced patient safety and satisfaction in clinical settings.

In June 2025, Dasi Simulations raised USD 5 million in venture funding from unspecified investors. The company plans to utilize this funding to expand its sales and engineering teams, advance the development of its artificial intelligence tools for structural heart care, and enhance customer support services. Dasi Simulations is focusing on launching new products and expanding into additional markets, particularly targeting growth in Europe alongside its existing operations in the United States.